about
Prevalence of asthma among Middle Eastern children: A systematic review.Environmental determinants of cardiovascular diseases risk factors: a qualitative directed content analysis.Patients' Experience of Tuberculosis Treatment Using Directly Observed Treatment, Short-Course (DOTS): A Qualitative StudyThe epidemiology of stroke in the Middle East and North Africa.Health policy analysis: a tool to evaluate in policy documents the alignment between policy statements and intended outcomes.Achieving a balanced life in the face of chronic illness.The population attributable fraction of stroke associated with high blood pressure in the Middle East and North Africa.Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades.Acute rheumatic fever: over-estimation or mis-conception?Does tax-based health financing offer protection from financial catastrophe? Findings from a household economic impact survey of ischaemic heart disease in Malaysia.Impact of Drinking Water Fluoride on Human Thyroid Hormones: A Case- Control Study.Population-attributable fraction of hypertension associated with obesity, abdominal obesity, and the joint effect of both in the Central Provinces of Iran.Informal care and the self-management partnership: implications for Australian health policy and practice.Cerebrovascular disease in 48 countries: secular trends in mortality 1950-2005.Predictors of blood pressure in a cohort of school-aged childrenPrevalence of modifiable cardiovascular risk factors in Yazd inner-city municipalitiesEpidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health studyAgreement between Framingham, IraPEN and non-laboratory WHO-EMR risk score calculators for cardiovascular risk prediction in a large Iranian populationAwareness, treatment, and control of hypertension and related factors in adult Iranian population
P50
Q33805604-B5733709-492A-4FCA-833B-6DA721345518Q33848322-01DAD9BC-602D-4E40-A33E-36D64C496929Q35645050-A99B0D6F-3E33-422A-AD5B-569E562F3F00Q37764454-ADBB2C2C-A862-4C69-BFBD-EB3AAF693B43Q37812409-8733430B-592B-47DB-874F-A10A11E0C5F5Q38426089-E6176A07-0FF7-4B8B-8264-A6863316E672Q39532111-3650CC58-0297-40E8-A751-EF3385E5E8CAQ43494640-A0AF5BF4-8234-4D30-90CE-3F4A197D6D22Q44220030-8F8E2E8D-F4F9-4EB3-AE3B-415C4120F5EFQ47597698-F5459A35-6FDF-4B67-B349-6998E3EC4D22Q49453977-5ADF79E6-F5EB-455D-8397-DB768306C6E6Q50110344-CBFFD471-EF01-4CB6-BC1C-D3B4FFDCD2B8Q50123287-D85577E9-8685-4BED-A888-C396DE4C917EQ50168629-13B2920F-BC51-4F26-8714-426DDD06490BQ81415426-62324A23-B4EF-4A85-8F6D-F8392312BC7DQ89449911-E9BCCBAC-6CD9-4925-8445-DE336C4ADDBBQ89513902-0557050A-18B4-45A0-B5D0-91C64C932097Q90641143-6D0FD0BC-E31B-4DA4-8688-FF9434647781Q94595759-2EC1FAC6-2940-45BF-82D3-E5E4FEA8728C
P50
description
researcher ORCID: 0000-0001-6455-0747
@en
name
Masoud Mirzaei
@ast
Masoud Mirzaei
@en
Masoud Mirzaei
@es
Masoud Mirzaei
@nl
Masoud Mirzaei
@sl
type
label
Masoud Mirzaei
@ast
Masoud Mirzaei
@en
Masoud Mirzaei
@es
Masoud Mirzaei
@nl
Masoud Mirzaei
@sl
prefLabel
Masoud Mirzaei
@ast
Masoud Mirzaei
@en
Masoud Mirzaei
@es
Masoud Mirzaei
@nl
Masoud Mirzaei
@sl
P106
P1153
14630507700
P31
P496
0000-0001-6455-0747